Kimia Biosciences [KIMIABL] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Kimia Biosciences Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Kimia Biosciences Ltd. wins in 4 metrics, Gujarat Themis Biosyn Ltd. wins in 8 metrics, with 0 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Kimia Biosciences Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) N/A 73.73 N/A
Price-to-Book Ratio 15.97 13.36 Gujarat Themis Biosyn Ltd.
Debt-to-Equity Ratio 311.45 27.04 Gujarat Themis Biosyn Ltd.
PEG Ratio N/A -17.55 N/A
EV/EBITDA 10.88 52.76 Kimia Biosciences Ltd.
Profit Margin (TTM) 7.19% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 18.95% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 18.95% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity N/A 19.64% N/A
Return on Assets (TTM) N/A 16.19% N/A
Free Cash Flow (TTM) N/A $-251.22M N/A
Dividend Yield N/A 0.17% N/A
1-Year Return -26.63% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 1.44 22.23 Kimia Biosciences Ltd.
Enterprise Value $2.10B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 1.67 22.65 Kimia Biosciences Ltd.
Gross Profit Margin (TTM) N/A 83.29% N/A
Revenue per Share (TTM) $27 $15 Kimia Biosciences Ltd.
Earnings per Share (Diluted) N/A $4.40 N/A
Beta (Stock Volatility) 0.89 -0.17 Gujarat Themis Biosyn Ltd.

Kimia Biosciences Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

KIMIABL
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kimia Biosciences Ltd.0.33%-9.12%-4.82%8.73%13.21%-6.14%
Gujarat Themis Biosyn Ltd.2.45%-7.03%7.92%39.85%0.71%-8.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kimia Biosciences Ltd.-26.63%2.24%-15.80%82.50%82.50%82.50%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Kimia Biosciences Ltd. vs Gujarat Themis Biosyn Ltd.

MetricKIMIABLGUJTHEM
Market Information
Market Cap i₹1.81B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,89179,452
90 Day Avg. Volume i7,027106,446
Last Close₹33.11₹411.65
52 Week Range₹23.20 - ₹86.85₹225.05 - ₹479.00
% from 52W High-61.88%-14.06%
All-Time High₹86.85 (Jul 02, 2025)₹479.00 (Oct 27, 2025)
% from All-Time High-61.88%-14.06%
Growth Metrics
Quarterly Revenue Growth0.00%0.10%
Quarterly Earnings Growth0.19%-0.04%
Financial Health
Profit Margin (TTM) i0.07%0.30%
Operating Margin (TTM) i0.19%0.40%
Return on Equity (TTM) iN/A0.20%
Debt to Equity (MRQ) i311.4527.04
Cash & Liquidity
Book Value per Share (MRQ)₹2.40₹24.29
Cash per Share (MRQ)₹0.15₹0.92
Operating Cash Flow (TTM) i₹0₹970.68M
Levered Free Cash Flow (TTM) i₹0₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹0.67

Valuation & Enterprise Metrics Analysis: Kimia Biosciences Ltd. vs Gujarat Themis Biosyn Ltd.

MetricKIMIABL (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A73.73
Forward P/E iN/AN/A
PEG Ratio iN/A-17.55
Price to Sales (TTM) i1.4422.23
Price to Book (MRQ) i15.9713.36
Market Capitalization
Market Capitalization i₹1.81B₹35.41B
Enterprise Value i₹2.10B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i1.6722.65
Enterprise to EBITDA i10.8852.76
Risk & Other Metrics
Beta i0.89-0.17
Book Value per Share (MRQ) i₹2.40₹24.29

Financial Statements Comparison: Kimia Biosciences Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricKIMIABLGUJTHEM (2025)
Revenue/Sales iN/A1.51B
Cost of Goods Sold iN/A318.78M
COGS % of Revenue i-21.1%
Gross Profit iN/A1.19B
Gross Margin i-78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) iN/A642.49M
Operating Margin i-42.6%
EBITDA iN/A713.04M
EBITDA Margin i-47.3%
Pre-Tax Income iN/A655.38M
Pre-Tax Income % of Revenue i-43.5%
Income Tax iN/A167.66M
Income Tax % of Revenue i-11.1%
Net Income (Profit) iN/A487.72M
Profit Margin i-32.3%

Balance Sheet & Liquidity Metrics

MetricKIMIABLGUJTHEM (2025)
Cash & Equivalents iN/A116.94M
Total Current Assets iN/A519.73M
Total Current Assets % of Revenue i-34.5%
Total Current Liabilities iN/A205.60M
Total Current Liabilities % of Revenue i-13.6%
Long-Term Debt iN/A296.36M
Long-Term Debt % of Revenue i-19.7%
Total Shareholders Equity iN/A2.48B
Retained Earnings iN/A2.37B
Retained Earnings % of Revenue i-157.4%
Property, Plant & Equipment iN/A411.30M

Cash Flow Statement Comparison

MetricKIMIABLGUJTHEM (2025)
Operating Cash Flow iN/A970.68M
Operating Cash Flow % of Revenue i-64.4%
Capital Expenditures iN/A-1.16B
Free Cash Flow iN/A-251.22M
FCF Margin i--16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKIMIABLGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i47.31M108.97M
Float Shares i2.55M29.52M
% Held by Insiders i91.00%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i9.00%26.84%

Dividend Analysis & Yield Comparison: Kimia Biosciences Ltd. vs Gujarat Themis Biosyn Ltd.

MetricKIMIABLGUJTHEM
Last 12-Month Dividend iN/A₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹0.67
Ex-Dividend DateN/ASep 04, 2025